Prognostic factors, pathophysiology and novel biomarkers in Crimean-Congo hemorrhagic fever

Antiviral Research

Volumn 132, Issue , 2016, Pages 233-243

  Akinci, Esragul ^a   Bodur, Hurrem ^a   Sunbul, Mustafa ^b   Leblebicioglu, Hakan ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Biochemistry; Crimean Congo hemorrhagic fever; Mortality; Outcome; Prognosis; Severity scoring; Viral load

Indexed keywords

BIOLOGICAL MARKER;

ADAPTIVE IMMUNITY; BIOCHEMICAL ANALYSIS; BLOOD CLOTTING DISORDER; CLINICAL DECISION MAKING; CRIMEAN CONGO HEMORRHAGIC FEVER; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DISEASE SEVERITY ASSESSMENT; DYING; HEREDITY; HUMAN; INNATE IMMUNITY; LABORATORY DIAGNOSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; REVIEW; SCORING SYSTEM; VIRUS LOAD; CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS; DISEASE MANAGEMENT; GENETIC PREDISPOSITION; META ANALYSIS; MORTALITY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT;

BIOMARKERS; CLINICAL DECISION-MAKING; DISEASE MANAGEMENT; GENETIC PREDISPOSITION TO DISEASE; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT; VIRAL LOAD;

EID: 84978397812     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2016.06.011     Document Type: Review

References (95)

1. Akıncı, E., Bodur, H., Leblebicioglu, H., Pathogenesis of Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 13 (2013), 429–437.
2. Akıncı, E., Bodur, H., Muşabak, U., Sağkan, R.I., The relationship between the human leukocyte antigen system and Crimean-Congo hemorrhagic fever in the Turkish population. Int. J. Infect. Dis. 17 (2013), 1038–1041.
3. Akinci, E., Yilmaz, M., Bodur, H., Ongürü, P., Bayazit, F.N., Erbay, A., Ozet, G., Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever. Int. J. Infect. Dis. 13 (2009), 560–563.
4. Aksoy, O., Parlak, E., Parlak, M., Aksoy, H., Serum β defensın-2 levels and their relationship with clinical course and prognosis in patients with crimean-congo hemorrhagic fever. Med. Princ. Pract. 25 (2016), 163–168.
5. Antoniadis, A., Casals, J., Serological evidence of human infection with Congo-Crimean hemorrhagic fever virus in Greece. Am. J. Trop. Med. Hyg. 31:5 (1982), 1066–1067.
6. Arslan, S., Engin, A., Özbilüm, N., Bakır, M., Toll-like receptor 7 Gln11Leu, c.4-151A/G, and +1817G/T polymorphisms in Crimean Congo hemorrhagic fever. J. Med. Virol. 87 (2015), 1090–1095.
7. Arslan, S., Engin, A., Relationship between NF-κB1 and NF-κBIA genetic polymorphisms and Crimean-Congo hemorrhagic fever. Scand. J. Infect. Dis. 44 (2012), 138–143.
8. Ascioglu, S., Leblebicioglu, H., Vahaboglu, H., Chan, K.A., Ribavirin for patients with Crimean- Congo haemorrhagic fever: a systematic review and meta-analysis. J. Antimicrob. Chemother. 66 (2011), 1215–1222.
9. Bakir, M., Engin, A., Kuskucu, M.A., Bakir, S., Gündag, O., Midilli, K., Relationship of plasma cell-free DNA level with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever. J. Med. Virol. 88:7 (2016), 1159–1167.
10. Bakır, M., Gözel, M.G., Köksal, I., Aşık, Z., Günal, Ö., Yılmaz, H., But, A., Yılmaz, G., Engin, A., Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF). Eur. J. Clin. Microbiol. Infect. Dis. 34 (2015), 325–330.
11. Bakir, M., Bakir, S., Sari, I., Celik, V.K., Gozel, M.G., Engin, A., Evaluation of the relationship between serum levels of VEGF and sVEGFR1 with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever. J. Med. Virol. 85 (2013), 1794–1801.
12. Bakir, M., Engin, A., Gozel, M.G., Elaldi, N., Kilickap, S., Cinar, Z., A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever. J. Vector Borne Dis. 49 (2012), 105–110.
13. Bakir, M., Ugurlu, M., Dokuzoguz, B., Bodur, H., Taşyaran, M., Vahaboglu, H., Turkish CCHF Study Group, Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J. Med. Microbiol. 54 (2005), 385–389.
14. Barut, S., Dincer, F., Sahin, I., Ozyurt, H., Akkus, M., Erkorkmaz, U., Increased serum ferritin levels in patients with Crimean-Congo hemorrhagic fever: can it be a new severity criterion?. Int. J. Infect. Dis. 14 (2010), e50–54.
15. Bastug, A., Kayaaslan, B., Kazancioglu, S., Aslaner, H., But, A., Akinci, E., Yetkin, M.A., Eren, S., Bodur, H., Prognostic factors in Crimean-Congo hemorrhagic fever and the effect of leukocyte counts on mortality. Jpn. J. Infect. Dis. 69 (2016), 51–55.
16. Bente, D.A., Forrester, N.L., Watts, D.M., McAuley, A.J., Whitehouse, C.A., Bray, M., Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antivir. Res. 100 (2013), 159–189.
17. Bente, D.A., Alimonti, J.B., Shieh, W.J., Camus, G., Ströher, U., Zaki, S., Jones, S.M., Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J. Virol. 84:21 (2010), 11089–11100.
18. Bodur, H., Akinci, E., Ascioglu, S., Öngürü, P., Uyar, Y., Subclinical infections with Crimean-Congo hemorrhagic fever virus. Turk. Emerg. Infect. Dis. 18 (2012), 640–642.
19. Bodur, H., Erbay, A., Akıncı, E., Öngürü, P., Bayazıt, N., Eren, S.S., Kubar, A., Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever. Int. J. Infect. Dis. 15 (2011), e44–47.
20. Bodur, H., Akinci, E., Ongürü, P., Uyar, Y., Baştürk, B., Gözel, M.G., Kayaaslan, B.U., Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever. Int. J. Infect. Dis. 14 (2010), e704–707.
21. Bozkurt, I., Sunbul, M., Yilmaz, H., Esen, S., Leblebicioglu, H., Beeching, N.J., Direct healthcare costs for patients hospitalized with Crimean-Congo haemorrhagic fever can be predicted by a clinical illness severity scoring system. Pathog. Glob. Health 110:1 (2016), 9–13.
22. Burt, F.J., Paweska, J.T., Ashkettle, B., Swanepoel, R., Genetic relationship in southern African Crimean-Congo haemorrhagic fever virus isolates: evidence for occurrence of reassortment. Epidemiol. Infect. 137:9 (2009), 1302–1308.
23. Burt, F.J., Swanepoel, R., Molecular epidemiology of African and Asian Crimean-Congo haemorrhagic fever isolates. Epidemiol. Infect. 133:4 (2005), 659–666.
24. Burt, F.J., Swanepoel, R., Shieh, W.J., Smith, J.F., Leman, P.A., Greer, P.W., Coffield, L.M., Rollin, P.E., Ksiazek, T.G., Peters, C.J., Zaki, S.R., Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch. Pathol. Lab. Med. 121:8 (1997), 839–846.
25. Celik, V.K., Sari, I., Engin, A., Gürsel, Y., Aydin, H., Bakir, S., Determination of serum adenosine deaminase and xanthine oxidase levels in patients with crimean-congo hemorrhagic fever. Clin. (Sao Paulo) 65 (2010), 697–702.
26. Cevik, M.A., Erbay, A., Bodur, H., Gülderen, E., Baştuğ, A., Kubar, A., Akinci, E., Clinical and laboratory features of Crimean- Congo hemorrhagic fever: predictors of fatality. Int. J. Infect. Dis. 12 (2008), 374–379.
27. Cevik, M.A., Erbay, A., Bodur, H., Eren, S.S., Akinci, E., Sener, K., Ongürü, P., Kubar, A., Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin. Infect. Dis. 45 (2007), e96–100.
28. Ceylan, B., Calıca, A., Ak, O., Akkoyunlu, Y., Turhan, V., Ribavirin is not effective against Crimean-Congo hemorrhagic fever: observations from the Turkish experience. Int. J. Infect. Dis. 17 (2013), e799–801.
29. Connolly-Andersen, A.M., Moll, G., Andersson, C., Akerström, S., Karlberg, H., Douagi, I., Mirazimi, A., Crimean-Congo hemorrhagic fever virus activates endothelial cells. J. Virol. 85:15 (2011), 7766–7777.
30. Connolly-Andersen, A.M., Magnusson, K.E., Mirazimi, A., Basolateral entry and release of Crimean-Congo hemorrhagic fever virus in polarized MDCK-1 cells. J. Virol. 81 (2007), 2158–2164.
31. Demirpençe, Ö., Doğan, H.O., Erşan, S., Şahin, M., Şahin, H., Bakır, M., Presepsin levels of patients with Crimean-Congo Hemorrhagic fever. Jpn. J. Infect. Dis., 2016 Mar 18 ([Epub ahead of print]).
32. Deyde, V.M., Khristova, M.L., Rollin, P.E., Ksiazek, T.G., Nichol, S.T., Crimean-Congo haemorrhagic fever virus genomics and global diversity. J. Virol. 80 (2006), 8834–8842.
33. Dokuzoguz, B., Celikbas, A.K., Gök, Ş.E., Baykam, N., Eroglu, M.N., Ergönül, Ö., Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality. Clin. Infect. Dis. 57 (2013), 1270–1274.
34. Duh, D., Saksida, A., Petrovec, M., Ahmeti, S., Dedushaj, I., Panning, M., Drosten, C., Avsic-Zupanc, T., Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg. Infect. Dis. 13 (2007), 1769–1772.
35. Duygu, F., Kaya, T., Baysan, P., Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?. Vector Borne Zoonotic Dis. 12 (2012), 812–816.
36. Ekiz, F., Gürbüz, Y., Basar, Ö., Aytekin, G., Ekiz, Ö., Sentürk, Ç.Ş., Aktas, B., Yılmaz, B., Altınbaş, A., Çoban, Ş., Şencan, İ., Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever. Clin. Appl. Thromb. Hemost. 19 (2013), 441–444.
37. Elaldi, N., Yilmaz, M., Bagci, B., Yelkovan, I., Bagci, G., Gozel, M.G., Engin, A., Bakir, M., Dokmetas, I., The relationship between IFNA1, IFNA5, IFNA10 and IFNA17 gene polymorphisms and Crimean-Congo Hemorrhagic Fever prognosis in a Turkish population range. J. Med. Virol., 2015, 10.1002/jmv.24456 ([Epub ahead of print]).
38. Elaldi, N., Bodur, H., Ascioglu, S., Celikbas, A., Ozkurt, Z., Vahaboglu, H., Leblebicioglu, H., Yilmaz, N., Engin, A., Sencan, M., Aydin, K., Dokmetas, I., Cevik, M.A., Dokuzoguz, B., Tasyaran, M.A., Ozturk, R., Bakir, M., Uzun, R., Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J. Infect. 58 (2009), 238–244.
39. Elevli, M., Ozkul, A.A., Civilibal, M., Midilli, K., Gargili, A., Duru, N.S., A newly identified Crimean-Congo hemorrhagic fever virus strain in Turkey. Int. J. Infect. Dis. 14:Suppl. 3 (2010), e213–e216.
40. Engin, A., Ugurlu, S., Caglar, E., Oztop, A.Y., Inan, D., Elaldi, N., Dokmetas, I., Bakir, M., Serum levels of Mannan-binding lectin in patients with Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 10 (2010), 1037–1041.
41. Engin, A., Arslan, S., Kizildag, S., Oztürk, H., Elaldi, N., Dökmetas, I., Bakir, M., Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever. Microbes Infect. 12 (2010), 1071–1078.
42. Ergonul, O., Celikbas, A., Baykam, N., Eren, S., Dokuzoguz, B., Analysis of risk factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin. Microbiol. Infect. 2 (2006), 551–554.
43. Ergonul, O., Tuncbilek, S., Baykam, N., Celikbas, A., Dokuzoguz, B., Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J. Infect. Dis. 193 (2006), 941–944.
44. Ergönül, O., Celikbaş, A., Dokuzoguz, B., Eren, S., Baykam, N., Esener, H., Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin. Infect. Dis. 39 (2004), 284–287.
45. Erturk, A., Cure, E., Parlak, E., Baydur Sahin, S., Yuce, S., Clinical significance of neutrophil gelatinase-associated lipocalin in Crimean-Congo hemorrhagic Fever. Biomed. Res. Int., 2015, 2015, 374010, 10.1155/2015/374010 Epub 2015 Jan 22.
46. Gul, S., Ozturk, D.B., Kisa, U., Kacmaz, B., Yesilyurt, M., Procalcitonin level and its predictive effect on mortality in Crimean-Congo hemorrhagic fever patients. Jpn. J. Infect. Dis. 68 (2015), 511–513.
47. Gurbuz, Y., Ozturk, B., Tutuncu, E.E., Sencan, I., Cicek Senturk, G., Altay, F.A., Evaluation of prognostic values of tissue plasminogen activator and plasminogen activator inhibitor-1 in crimean-congo hemorrhagic fever patients. Jundishapur J. Microbiol., 8, 2015, e26514.
48. Hasanoglu, I., Guner, R., Carhan, A., Kocak Tufan, Z., Yagci-Caglayik, D., Guven, T., Yilmaz, G.R., Tasyaran, M.A., Crucial parameter of the outcome in Crimean Congo hemorrhagic fever: viral load. J. Clin. Virol. 75 (2016), 42–46.
49. Hatipoglu, C.A., Bulut, C., Yetkin, M.A., Ertem, G.T., Erdinc, F.S., Kilic, E.K., Sari, T., Kinikli, S., Oral, B., Demiroz, A.P., Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey. Scand. J. Infect. Dis. 42 (2010), 516–521.
50. Kaya, S., Elaldi, N., Kubar, A., Gursoy, N., Yilmaz, M., Karakus, G., Gunes, T., Polat, Z., Gozel, M.G., Engin, A., Dokmetas, I., Bakir, M., Yilmaz, N., Sencan, M., Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-α, IL-6, IL-10, and IFN-γlevels in patients with Crimean-Congo hemorrhagic fever. BMC Infect. Dis., 14, 2014, 416.
51. Kazancıoğlu, S., Akinci, E., Bastug, A., Kayaaslan, B., But, A., Aslaner, H., Eren, S.S., Yetkin, M.A., Bodur, H., Does the course of laboratory parameters help us to predict the outcome of CCHF?. Turk. J. Med. Sci. 46 (2016), 328–334.
52. Koksal, I., Yilmaz, G., Aksoy, F., Aydin, H., Yavuz, I., Iskender, S., Akcay, K., Erensoy, S., Caylan, R., Aydin, K., The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J. Clin. Virol. 47 (2010), 65–68.
53. Kurt, Y.G., Cayci, T., Onguru, P., Akgul, E.O., Yaman, H., Aydin, I., Bodur, H., Turker, T., Kurt, I., Cevik, M.A., Erbil, M.K., Serum chitotriosidase enzyme activity in patients with Crimean-Congo hemorrhagic fever. Clin. Chem. Lab. Med. 47 (2009), 1543–1547.
54. Leblebicioglu, H., Ozaras, R., Sunbul, M., Crimean-Congo Hemorrhagic Fever: a neglected infectious diseases with potential nosocomial infection threat. Am. J. Infect. Control, 2016 (in press).
55. Leblebicioglu, H., Ozaras, R., Irmak, H., Sencan, I., Crimean-Congo hemorrhagic fever in Turkey: current status and future challenges. Antivir. Res. 126 (2016), 21–34.
56. Leblebicioglu, H., Sunbul, M., Bodur, H., Ozaras, R., Crimean-Congo Haemorrhagic Fever Research Network of Turkey (CCRNT), Discharge criteria for Crimean-Congo haemorrhagic fever in endemic areas. J. Infect. 72:4 (2016), 500–501.
57. Leblebicioglu H., Crimean-Congo Hemorrhagic Fever. In: UpToDate, Hirsch MS (Ed), UpToDate, Waltham, MA. (Accessed on May 29, 2016.).
58. Leblebicioglu, H., Bodur, H., Dokuzoguz, B., Elaldi, N., Guner, R., koksal, I., Kurt, H., Senturk, G.C., Case management and supportive treatment for patients with crimean-congo hemorrhagic fever. Vector Borne Zoonotic Dis. 12 (2012), 805–811.
59. Leblebicioglu, H., Crimean-Congo haemorrhagic fever in Eurasia. Int. J. Antimicrob. Agents. 36:Suppl. 1 (2010), S43–S46.
60. Mardani, M., Jahromi, M.K., Naieni, K.H., Zeinali, M., The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran. Clin. Infect. Dis. 36 (2003), 1613–1618.
61. Mentese, A., Koksal, I., Sumer, A.U., Arslan, M., Karahan, S.C., Yılmaz, G., Diagnostic and prognostic value of Ischemia-modified albumin in patients with Crimean-Congo hemorrhagic fever. J. Med. Virol. 85 (2013), 684–688.
62. Mentese, A., Yilmaz, G., Sümer, A., Arslan, M., Karahan, S.C., Köksal, I., The diagnostic and prognostic significance of SCUBE1 levels in Crimean-Congo hemorrhagic fever. Int. J. Infect. Dis. 17 (2013), e1042–1045.
63. Metanat, M., Sharifi-Mood, B., Tabatabaei, M., Sarraf-Shirazi, M., Can serum ferritin level predict disease severity in patients with crimean-congo hemorrhagic Fever?. Eurasian J. Med. 45 (2013), 108–114.
64. Midilli, K., Gargili, A., Ergonul, O., Elevli, M., Ergin, S., Turan, N., Sengöz, G., Ozturk, R., Bakar, M., The first clinical case due to AP92 like strain of Crimean-Congo Hemorrhagic Fever virus and a field survey. BMC Infect. Dis., 10(9), 2009, 90.
65. Onguru, P., Dagdas, S., Bodur, H., Yilmaz, M., Akinci, E., Eren, S., Ozet, G., Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J. Clin. Lab. Anal. 24 (2010), 163–166.
66. Onguru, P., Akgul, E.O., Akinci, E., Yaman, H., Kurt, Y.G., Erbay, A., Bayazit, F.N., Bodur, H., Erbil, K., Acikel, C.H., Cevik, M.A., High serum levels of neopterin in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J. Infect. 56 (2008), 366–370.
67. Ozkaya, E., Dincer, E., Carhan, A., Uyar, Y., Ertek, M., Whitehouse, C.A., Ozkul, A., Molecular epidemiology of Crimean-Congo hemorrhagic fever virus in Turkey: occurrence of local topotype. Virus Res. 149:1 (2010), 64–70.
68. Ozkurt, Z., Ozden, K., Kiki, I., Usanmaz, M., Prognostic significance of antithrombin activity in patients with crimean-congo hemorrhagic Fever. Eurasian J. Med. 43 (2011), 83–86.
69. Ozkurt, Z., Kiki, I., Erol, S., Erdem, F., Yilmaz, N., Parlak, M., Gundogdu, M., Tasyaran, M.A., Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J. Infect. 52 (2006), 207–215.
70. Ozturk, B., Tutuncu, E., Kuscu, F., Gurbuz, Y., Sencan, I., Tuzun, H., Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions. Int. J. Infect. Dis. 16 (2012), e89–93.
71. Ozturk, B., Kuscu, F., Tutuncu, E., Sencan, I., Gurbuz, Y., Tuzun, H., Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever. J. Clin. Virol. 47 (2010), 115–119.
72. Özmen, Z., Albayrak, E., Özmen, Z.C., Aktaş, F., Aktas, T., Duygu, F., The evaluation of abdominal findings in Crimean-Congo hemorrhagic fever. Abdom. Radiol. (NY) 41:2 (2016), 384–390.
73. Papa, A., Tsergouli, K., Çağlayık, D.Y., Bino, S., Como, N., Uyar, Y., Korukluoglu, G., Cytokines as biomarkers of Crimean-Congo hemorrhagic fever. J. Med. Virol. 88:1 (2016), 21–27.
74. Papa, A., Bino, S., Velo, E., Harxhi, A., Kota, M., Antoniadis, A., Cytokine levels in Crimean-Congo hemorrhagic fever. J. Clin. Virol. 36 (2006), 272–276.
75. Saksida, A., Duh, D., Wraber, B., Dedushaj, I., Ahmeti, S., Avsic-Zupanc, T., Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever. Clin. Vaccine Immunol. 17 (2010), 1086–1093.
76. Salehi-Vaziri, M., Baniasadi, V., Jalali, T., Mirghiasi, S.M., Azad-Manjiri, S., Zarandi, R., Mohammadi, T., Khakifirouz, S., Fazlalipour, M., The first fatal case of Crimean-Congo Hemorrhagic Fever due to AP92 like strain of Crimean-Congo Hemorrhagic Fever virus. Jpn. J. Infect. Dis., 2016 [Epub ahead of print].
77. Sari, I., Bakir, S., Engin, A., Aydin, H., Poyraz, O., Some acute phase reactants and cholesterol levels in serum of patient with Crimean-Congo haemorrhagic fever. Bosn. J. Basic Med. Sci. 13 (2013), 21–26.
78. Soares-Weiser, K., Thomas, S., Thomson, G., Garner, P., Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis. BMC Infect. Dis., 2010(10), 2010, 207.
79. Sonmez, M., Aydin, K., Durmus, A., Sucu, N., Yilmaz, M., Akdogan, E., Koksal, I., Ovali, E., Omay, S.B., Plasma activity of thrombin activatable fibrinolysis inhibitor in Crimean-Congo hemorrhagic fever. J. Infect. 55 (2007), 184–187.
80. Sunbul, M., Leblebicioglu, H., Fletcher, T.E., Elaldi, N., Ozkurt, Z., Bastug, A., Yilmaz, G., Guner, R., Duygu, F., Beeching, N.J., Crimean-Congo haemorrhagic fever and secondary bacteraemia in Turkey. J. Infect. 71 (2015), 597–599.
81. Swanepoel, R., Gill, D.E., Shepherd, A.J., Leman, P.A., Mynhardt, J.H., Harvey, S., The clinical pathology of Crimean-Congo hemorrhagic fever. Rev. Infect. Dis. 11:Suppl. 4 (1989), S794–S800.
82. Turkdogan, K.A., Eren, S.H., Coskun, A., Engın, A., Sonmez, E., Cıvelek, C., Ratio of neutrophil to lymphocyte counts in crimean Congo hemorrhagic fever. J. Clin. Anal. Med. 7:1 (2016), 10–13.
83. Turkdogan, K.A., Zorlu, A., Engin, A., Guven, F.M., Polat, M.M., Turgut, O.O., Yilmaz, M.B., C-type natriuretic peptide is associated with the severity of Crimean-Congo hemorrhagic fever. Int. J. Infect. Dis. 16 (2012), e616–620.
84. Vorou, R., Pierroutsakos, I.N., Maltezou, H.C., Crimean-Congo hemorrhagic fever. Curr. Opin. Infect. Dis. 20 (2007), 495–500.
85. Weber, F., Mirazimi, A., Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis. Cytokine Growth Factor Rev. 19 (2008), 395–404.
86. Wölfel, R., Paweska, J.T., Petersen, N., Grobbelaar, A.A., Leman, P.A., Hewson, R., Georges-Courbot, M.C., Papa, A., Günther, S., Drosten, C., Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg. Infect. Dis. 13 (2007), 1097–1100.
87. Yesilyurt, M., Gul, S., Ozturk, B., Kayhan, B.C., Celik, M., Uyar, C., Erdogan, F., The early prediction of fatality in Crimean Congo hemorrhagic fever patients. Saudi Med. J. 32 (2011), 742–743.
88. Yilmaz, G., Mentese, A., Yilmaz, H., Koksal, İ., Importance of serum adipokine and ghrelin levels in patients with Crimean-Congo hemorrhagic fever. J. Med. Virol. 87 (2015), 310–314.
89. Yilmaz, G., Mentese, A., Kaya, S., Uzun, A., Karahan, S.C., Koksal, I., The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in Crimean-Congo hemorrhagic fever. J. Clin. Virol. 50 (2011), 209–211.
90. Yilmaz, G., Koksal, I., Topbas, M., Yilmaz, H., Aksoy, F., The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria. J. Clin. Virol. 47 (2010), 361–365.
91. Yilmaz, G.R., Buzgan, T., Irmak, H., Safran, A., Uzun, R., Cevik, M.A., Torunoglu, M.A., The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007. Int. J. Infect. Dis. 13 (2009), 380–386.
92. Yilmaz, H., Yilmaz, G., Kostakoğlu, U., Yaman, H., Örem, A., Köksal, İ., The prognostic significance of serum troponin T levels in Crimean-Congo Hemorrhagic Fever patients. J. Med. Virol., 2015, 10.1002/jmv.24454 Dec 22 [Epub ahead of print].
93. Yilmaz, M., Elaldi, N., Bagci, B., Sari, I., Gümüs, E., Yelkovan, I., Effect of tumour necrosis factor-alpha and interleukin-6 promoter polymorphisms on course of Crimean-Congo hemorrhagic fever in Turkish patients. J. Vector Borne Dis. 52 (2015), 30–35.
94. Yilmaz, M., Aydin, K., Akdogan, E., Sucu, N., Sonmez, M., Omay, S.B., Koksal, I., Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever. J. Clin. Virol. 42 (2008), 415–417.
95. Yilmaz, M.B., Engin, A., Bektasoglu, G., Zorlu, A., Ege, M.R., Bakir, M., Dokmetas, I., Does electrocardiography at admission predict outcome in Crimean -Congo hemorrhagic fever?. J. Vector Borne Dis. 48 (2011), 150–154.